Nivolumab vs Valproic Acid
Nivolumab vs Valproic Acid: Overview
This comparison examines the pharmacological differences between Nivolumab and Valproic Acid.
Mechanism of Action
Nivolumab: Fully human anti-PD-1 IgG4 monoclonal antibody restoring T-cell anti-tumor activity.
Valproic Acid: Enhances GABA transmission and blocks sodium/calcium channels.
Pharmacokinetics
Half-life: Nivolumab — 27 days; Valproic Acid — 9-16 hours.
Chemical Properties
Molecular Formula: Valproic Acid — C8H16O2.
Molecular Weight: Valproic Acid — 144.2110 g/mol.
Type: Nivolumab — Antibody; Valproic Acid — Small molecule.